Skip to main content

Rothblatt Martine A's Form 4 filing

United Therapeutics Corp (UTHR) · filed Apr 24, 2023

Accession no.
0001415889-23-006805
Filed
Apr 24, 2023
Trade date
Apr 20-21, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.63M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rothblatt Martine ACIK 0001106578Director, Officer (CHAIRPERSON & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 20, 2023Common StockMOption exerciseAcquired+8,000$113.08+$904,6408,130Direct
Apr 20, 2023Common StockSSaleDisposed−835$223.76F2−$186,839.67,295Direct
Apr 20, 2023Common StockSSaleDisposed−6,099$224.94F3−$1,371,909.061,196Direct
Apr 20, 2023Common StockSSaleDisposed−1,066$225.61F4−$240,500.26130Direct
Apr 21, 2023Common StockMOption exerciseAcquired+8,000$113.08+$904,6408,130Direct
Apr 21, 2023Common StockSSaleDisposed−1,307$226.57F5−$296,126.996,823Direct
Apr 21, 2023Common StockSSaleDisposed−1,631$227.47F6−$371,003.575,192Direct
Apr 21, 2023Common StockSSaleDisposed−1,250$228.80F7−$286,0003,942Direct
Apr 21, 2023Common StockSSaleDisposed−1,800$229.73F8−$413,5142,142Direct
Apr 21, 2023Common StockSSaleDisposed−2,012$230.57F9−$463,906.84130Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 20, 2023Common StockMOption exerciseDisposed−8,000$0.00$064,000Direct
Apr 21, 2023Common StockMOption exerciseDisposed−8,000$0.00$056,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $223.415 to $224.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $224.425 to $225.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $225.43 to $225.785. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $225.94 to $226.905. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $227.05 to $228.035. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $228.15 to $229.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F8

This transaction was executed in multiple trades at prices ranging from $229.16 to $230.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $230.40 to $230.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)